HQ Curve in Centrifugal LVAD

Date
September 10, 2025
URL
https://x.com/WithAScalpel/status/1965740893274882426
Categories
VAD

HQ Curve in Centrifugal LVADs

Durable centrifugal LVADs are governed by a pump performance (H–Q) curve relating head (ΔP = P_Ao − P_LV) to flow (Q) at a given impeller speed and blood properties. At a fixed speed, centrifugal pumps display a negatively sloped, curvilinear H–Q relationship: as the circulation demands more head (higher afterload or lower preload), achievable flow falls. The patient’s system curve—set by aortic pressure (afterload) and LV filling pressure (preload)—intersects the pump curve to determine the operating point. This framework is consistent across modern continuous-flow devices and underpins day-to-day interpretation of speed, flow, power, and pulsatility indices on the console [1].

image

Interaction with the cardiac cycle (why “continuous-flow” looks phasic)

Even at constant speed, ΔP oscillates beat-to-beat with native LV pressure, so the operating point moves along the H–Q curve: during systole, LV pressure approaches aortic pressure (ΔP falls ⇒ Q rises); during diastole, LV pressure falls (ΔP rises ⇒ Q falls). Result: console-estimated flow peaks in systole and ebbs in diastole despite a fixed rpm—pulsatility created by the heart–pump interaction rather than the motor itself [2,5].

What shifts the operating point?

1) Pump speed

Raising speed generates a new family of H–Q curves (affinity behavior: head ~ speed²; flow ~ speed), increasing available head and flow—but only within safe preload/afterload limits [1].

2) Afterload (aortic pressure)

Higher aortic pressure increases ΔP and reduces pump flow at a given speed. Clinically, treating hypertension or outflow-graft obstruction improves output without reflexively increasing speed; targeted afterload reduction can promptly reverse low-flow states driven by high SVR [3].

3) Preload (LV filling pressure)

Higher LV filling lowers ΔP and raises flow. Preload starvation—from RV failure, hypovolemia, tamponade, or excessive PEEP—raises ΔP and limits flow at any speed. Attempting to “fix” this with speed alone invites suction events (septal shift, mitral inflow collapse). Hemodynamic (invasive or echo-guided) ramp testing ties these changes to measurable shifts in LV dimensions, filling pressures, and PI, guiding safe speed optimization [4,6].

4) Blood properties and hydraulics

Viscosity/hematocrit and cannula/graft geometry (small inflow, septal apposition, outflow kinks) add hydraulic losses that act like extra afterload and flatten achievable flow for a given speed [5].

Interpreting the console (device-agnostic)

  • Speed (rpm) selects the H–Q family.
  • Estimated flow is model-derived (power/torque); trends outweigh single values.
  • Power rises with flow and with thrombus/hemolysis; power step-ups at constant speed/BP warrant evaluation.
  • Pulsatility indices (e.g., PI) reflect the amplitude of phasic flow variation; a sudden fall suggests low preload or suction, whereas a rise often indicates better LV filling or lower afterload [1,4].

Bedside application (evidence-anchored)

  • Hypertension after LVAD implant. High MAP ⇒ ΔP↑ ⇒ Q↓. Reduce afterload (vasodilators) and reassess; speed escalation is usually unnecessary and can worsen suction risk [3].
  • Right-ventricular failure. Preload falls ⇒ ΔP↑ ⇒ Q↓; PI often drops and suction alarms may appear. Treat the RV first (optimize volume, reduce PVR with O₂/iNO, add inotrope) before adjusting speed [1,4].
  • Hypotension with high displayed flow. Low SVR ⇒ ΔP small ⇒ Q high. Think vasoplegia/bleeding/sepsis; correct SVR rather than increasing speed [1].
  • Ramp studies (outpatient optimization). With stepwise speed increases: flow should rise and LV end-diastolic dimension fall without suction or septal shift; plateaued flow or rising power at higher speeds signals hydraulic limits (preload restriction, outflow obstruction, or increased viscosity) rather than inadequate speed [4,6].
  • Aortic regurgitation. Part of pump output recirculates into the LV, inflating console flow without effective systemic perfusion; manage the valve pathology, not the pump setting [1,6].

Practical guardrails

  • Adjust speed only after confirming adequate preload and acceptable afterload.
  • Treat suction by lowering speed and restoring preload; treat afterload-related low flow by reducing afterload.
  • Track MAP, end-organ markers, and hemolysis labs alongside console data to avoid over-interpreting modeled flow [1–4].

Summary

The H–Q framework provides a single, coherent lens for LVAD care: at any fixed speed, pump flow is whatever the circulation’s pressure head allows. Because ΔP swings with the native cardiac cycle, continuous-flow pumps are functionally phasic. Interventions that raise LV filling or lower aortic pressure move the operating point toward higher flow; the converse moves it toward lower flow. Applying this model—validated across invasive/echo ramp protocols and bedside hemodynamic studies—supports safer speed titration, earlier recognition of suction and afterload-mediated low flow, and more rational use of console parameters in daily practice [1–6].

References

[1] Belkin MN, Imamura T, Narang N, Topkara VK. Hemodynamic principles of durable left ventricular assist devices. Artif Organs. 2022;46(10):1991–2006.

[2] Akimoto T, Yamazaki K, Litwak P, Kameneva MV, Kormos RL, Antaki JF. Pulsatile effect of an axial flow blood pump assessed by a neonatal animal model. ASAIO J. 2000;46(3):315–319.

[3] Rosenbaum AN, Cowger JA, Chen D, Zepeda R, Pereira NL, Stulak JM. Correction of high afterload improves low cardiac output in patients with left ventricular assist devices. ASAIO J. 2021;67(10):e159–e163.

[4] Uriel N, Morrison KA, Garan AR, et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia Ramp Study. J Am Coll Cardiol. 2012;60(18):1764–1775.

[5] Stanfield JR, Selzman CH, Croft LR, et al. In vitro pulsatility analysis of axial-flow and centrifugal left ventricular assist devices. Biomed Eng Online. 2013;12:138.

[6] Najjar E, Columbus J, Cho M, et al. Validation of the non-invasive ramp test in continuous-flow left ventricular assist devices. ESC Heart Fail. 2020;7(6):4324–4335.